BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence
BioMarin Pharmaceutical and Deep Genomics announced that the companies have entered into a preclinical collaboration that will use Deep Genomics' artificial intelligence drug discovery platform (…